Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ninjinyoeito for frailty in COPD patients
jRCTs031210140Active, not recruiting
- Sponsor
- Kracie
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and Fragility comparing Ninjinyoeito with Placebo (2 arms). Primary endpoint: Grip strength. Started Oct 2021; status: active, not recruiting.
02
Drugs
ninjinyoeito
03
Conditions
chronic obstructive pulmonary disease (COPD)Fragility
Beyond the preview
Go deeper on jRCTs031210140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210140.